Be in the know. 10 key reads for Tuesday…

  1. Biogen Stock Is Soaring as Hope Returns for Alzheimer’s Drug (MarketWatch)
  2. $8 Billion Fund Manager Picks Battered Indian Auto Stocks (Bloomberg)
  3. Biden Regains Lead, Warren Too Extreme (Mish Talk)
  4. Chinese vice foreign minister says progress made in trade talks with U.S. (Reuters)
  5. Pierre Delecto? Mitt Romney’s Secret Twitter Account Is Unveiled (Bloomberg)
  6. FDA approves new breakthrough therapy for cystic fibrosis (Vertex Pharma) (FDA)
  7. A Commodities Hedge Fund Titan Is Quitting After 50 Years (Hellenic Shipping News)
  8. Foreign Stocks Are Looking Cheap. 5 Ways to Take Advantage. (Barron’s)
  9. Last-Minute Opioid Deal Could Open Door to Bigger Settlement (Wall Street Journal)
  10. SAP Extends Cloud Partnership With Microsoft (Wall Street Journal)

Be in the know. 10 key reads for Monday…

  1. It’s Time to Stop Playing Defense in Stocks (Barron’s)
  2. Johnson Prepares to Put Brexit Deal to Vote After Foiled First Try (Wall Street Journal)
  3. Frackers Float ‘Shale Bonds’ as Traditional Investors Flee (Wall Street Journal)
  4. Goldman Sachs says pound could hit $1.35 as risk of no-deal Brexit fades (MarketWatch)
  5. Fed Poised to Cut, Goodbye to Draghi, Appropriate Yuan: Eco Day (Bloomberg)
  6. ECB Restarting QE Will Need More Purchase of Private Debt (Bloomberg)
  7. Robert Shiller: Recession likely years away due to bullish Trump effect (CNBC)
  8. The Chip Industry Gets a Strong 5G Signal (Wall Street Journal)
  9. The Week Ahead In Biotech: Earnings Trickle In, While Glaxo, Melinta, Foamix And Eton Await FDA Verdict (Yahoo Finance!)
  10. China’s growth slumped to a record low last quarter — and it could drop even lower next year, the IMF warns (Business Insider)